Syntara Limited has released a press release.
Continuation of trading halt
Earlier from Syntara
- Positive FDA feedback for Amsulostat P2b trial
- Half Year Report and Appendix 4D
- Quarterly Activities/Appendix 4C Cash Flow Report
- Amsulostat and Garvan in MRFF funded pancreatic trial